Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

N-acetylcysteine may help treat trichotillomania.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Spironolactone is effective and safe for treating acne with minimal side effects.

Spironolactone effectively treats female pattern hair loss with few side effects.

Ketoconazole may help regrow hair and increase follicle size, but more research needed.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Combining hair transplantation with microneedling or laser and UV light may help treat tough vitiligo on hands and feet, with microneedling being affordable and easy to learn.

Cannabinoids may help some skin conditions but more research is needed.

Mesotherapy might improve hair growth, but more research is needed to confirm its safety and effectiveness.

The new PRP treatment significantly improves hair growth.

PRP therapy increases hair density for androgenetic alopecia.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Twice-weekly 5 mg betamethasone helps hair regrowth in alopecia areata.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Minoxidil effectively treats stress-induced non-scarring hair loss.

Systemic cyproterone acetate and 5% topical minoxidil are effective and safe for treating female pattern hair loss.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Ringworm in cattle can be effectively treated with Povidone iodine and Whitefield ointment.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.